CharlesLeVeaMD

PubMed

• Evaluation of the serotonin pathway as a biomarker in cholangiocarcinoma.
  Christos Fountzilas, Sylvia Alarcon Velasco, Wiam Bshara, Charles M LeVea, Medhavi Gupta, Wenyan Ji, Anthony George, Kristopher Attwood, Renuka V Iyer> ;Journal of Gastrointestinal Oncology. 2023 Oct 31
• 1 citations
  Case Report: Immune Checkpoint Inhibitor-Induced Exuberant Tumor Inflammation With Accelerated Clinical Deterioration in Metastatic Renal Cell Carcinoma.
  Dharmesh Gopalakrishnan, Rohit Jain, Laurie Herbst, Marcus Sikorski, Silpa Mandava, Gissou Azabdaftari, Bo Xu, Charles LeVea, Kevin T. Robillard, Marc S. Ernstoff, Sab...> ;Frontiers in Oncology. 2021 Apr 29
• 1 citations
  Case reports on a gastric mass presenting with regional lymphadenopathy: A differential diagnosis is gastric schwannoma.
  Arnav Wadhawan, Maureen Brady, Charles LeVea, Steven N. Hochwald, Moshim Kukar> ;International Journal of Surgery Case Reports. 2020 Jan 1
• 16 citations
  A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients.
  Wen Wee Ma, Hao Xie, Gerald J. Fetterly, Laura Pitzonka, Amy Whitworth, Charles LeVea, John Wilton, Krystin Mantione, Grace K. Dy, Patrick McKay Boland, Renuka Iyer, W...> ;American Journal of Clinical Oncology. 2019 Feb 1
• 11 citations
  Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing
  Grace K. Dy, Mary Nesline, Antonios Papanicolau-Sengos, Paul DePietro, Charles LeVea, Amy P. Early, Hongbin Chen, Anne Grand'Maison, Patrick McKay Boland, Marc S. Erns...> ;BMC Medical Informatics and Decision Making. 2019 Jan 18
• 31 citations
  Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study
  Sandeep Samuel, Sarbajit Mukherjee, Nischala Ammannagari, Venkata K. Pokuri, Boris W. Kuvshinoff, Adrienne Groman, Charles LeVea, Renuka Iyer> ;Plos One. 2018 Jun 11
• 2 citations
  Depth of Muscularis Propria Invasion Does Not Prognosticate Survival in T2 Esophageal Adenocarcinoma.
  Christopher W. Seder, Brett Mahon, Mark Hennon, Mathew Thomas, Charles LeVea, Kristina A. Matkowskyj, Murli Krishna, Robert Medairos, Ryan A. Macke, Sanjib Basu, Justi...> ;Anticancer Research. 2018 Apr 1
• 12 citations
  A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent
  Christos Fountzilas, Ravi Chhatrala, Nikhil I. Khushalani, Wei Tan, Charles LeVea, Alan D. Hutson, Chris Tucker, Wen Wee Ma, Graham W. Warren, Patrick McKay Boland, Re...> ;Cancer Chemotherapy and Pharmacology. 2017 Jul 12
• 51 citations
  Lymphovascular and perineural invasion are associated with poor prognostic features and outcomes in colorectal cancer: A retrospective cohort study.
  Eisar Al-Sukhni, Kristopher Attwood, Emmanuel Gabriel, Charles LeVea, Kazunori Kanehira, Steven J. Nurkin> ;International Journal of Surgery. 2017 Jan 1
• 2 citations
  Key gaps in pathologic reporting for appendiceal mucinous neoplasms: time for universal synoptic reporting?
  Eisar Al-Sukhni, Charles LeVea, Joseph J. Skitzki, John M. Kane, Valerie Francescutti> ;Annals of Diagnostic Pathology. 2016 Oct 1
• 13 citations
  Ki67 score as a potential predictor in the selection of liver-directed therapies for metastatic neuroendocrine tumors: a single institutional experience
  Smit Singla, Charles LeVea, Venkata K. Pokuri, Kristopher Attwood, Garin Tomaszewski, Boris W. Kuvshinoff, Renuka Iyer> ;Journal of Gastrointestinal Oncology. 2016 Jun 1
• An ectopic biliary calculus mimicking gastric neoplasm: A late complication of spilled gallstones.
  Raed M. Alnaji, Moshim Kukar, Amanpal Singh, Charles LeVea, Steven N. Hochwald> ;Surgery. 2016 Feb 1
• 1 citations
  Modulating gut immunity and neoplasia with oral cytokine adjuvants
  Hatice Ozbilge, Charles LeVea, Allen Y. Chung, Qingsheng Li, Nejat K. Egilmez> ;Oncoimmunology. 2015 Jan 22
• 30 citations
  Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma.
  Sean T. Glenn, Craig A. Jones, Sandra Sexton, Charles LeVea, Susan M. Caraker, G. Hajduczok, Kenneth W. Gross> ;Oncogene. 2014 Dec 11
• 29 citations
  Oral interleukin-10 alleviates polyposis via neutralization of pathogenic T-regulatory cells.
  Allen Y. Chung, Qingsheng Li, Sarah J. Blair, Magdia De Jesus, Kristen L. Dennis, Charles LeVea, Jin Yao, Yijun Sun, Thomas F. Conway, Lauren P. Virtuoso, Nicholas G. ...> ;Cancer Research. 2014 Oct 1
• 9 citations
  Breast cancer resistance protein (BCRP) and excision repair cross complement-1 (ERCC1) expression in esophageal cancers and response to cisplatin and irinotecan based ...
  Anubha Bharthuar, S. Rehman, Jennifer D. Black, Charles LeVea, Usha Malhotra, Terry Mashtare, Renuka Iyer> ;Journal of Gastrointestinal Oncology. 2014 May 13
• 3 citations
  Oral Floor and Gingival Metastasis of Cholangiocarcinoma: A Case Report and Review of the Literature
  Yukihiro Nakanishi, Bo Xu, Charles LeVea> ;Case Reports in Pathology. 2014 May 7
• 3 citations
  Sexual dimorphism, weight gain and glucose intolerance in a B- and T-cell deficient mouse model.
  Zachary A.P. Wintrob, Emmanuel K. Oppong, Matthew Foster, Michael Martorana, Yu C. Tse, Li Zhong, Jeffery M. Welt, Hans R. Boateng, Ioana M. Drumea, John Irlam, Charle...> ;Cytokine. 2014 Jun 1
• 11 citations
  Outcomes of endoscopic resection for high-grade dysplasia and esophageal cancer.
  Steven J. Nurkin, Hector R. Nava, Sai Yendamuri, Charles LeVea, C. E. Nwogu, Adrienne Groman, Gregory E. Wilding, Andrew Bain, Steven N. Hochwald, Nikhil I. Khushalani> ;Surgical Endoscopy. 2014 Apr 1
• 52 citations
  Eculizumab therapy for gemcitabine induced hemolytic uremic syndrome: case series and concise review
  Omar Al Ustwani, James W. Lohr, Grace K. Dy, Charles LeVea, Gregory C. Connolly, Pradeep Arora, Renuka Iyer> ;Journal of Gastrointestinal Oncology. 2014 Feb 1
• 33 citations
  Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models
  Hao Zhang, Bonnie L. Hylander, Charles LeVea, Elizabeth A. Repasky, Robert M. Straubinger, Alex A. Adjei, Wen Wee Ma> ;British Journal of Cancer. 2014 Jan 21
• 12 citations
  Neoadjuvant chemoradiotherapy for esophageal/gastroesophageal carcinoma.
  Timothy A. Platz, Steven J. Nurkin, Mei Ka Fong, Adrienne Groman, Leayn Flaherty, Usha Malhotra, Charles LeVea, Sai Yendamuri, Graham W. Warren, Hector R. Nava, Kilian...> ;Journal of Gastrointestinal Oncology. 2013 Apr 17
• 24 citations
  Erlotinib and radiation therapy for elderly patients with esophageal cancer - Clinical and correlative results from a prospective multicenter phase 2 trial
  Renuka Iyer, Ravi Chhatrala, Tracey Shefter, Gary Y. Yang, Usha Malhotra, Wei Tan, Charles LeVea, Melissa Robins, Nikhil I. Khushalani> ;Oncology. 2013 Jan 1
• 5 citations
  Secondary Tumors of the Pancreas: Case Report and a Single-Center Experience.
  Akriti Dewanwala, Adam S. Kotowski, Charles LeVea, Wen Wee Ma> ;Journal of Gastrointestinal Cancer. 2012 Sep 1
• 20 citations
  Nephrogenic Adenoma of the Urinary Tract A Review
  Borislav A. Alexiev, Charles LeVea> ;International Journal of Surgical Pathology. 2012 Mar 13
• Join now to see all

Journal Articles

• Schwannoma of the seminal vesicle in a patient with rectal cancer  
  Jared Rocky Funston, Charles LeVea, Ashwani Rajput, Case Reports in Clinical Pathology, 1/1/2015
• Modulating Gut Immunity and Neoplasia with Oral Cytokine Adjuvants  
  Hatice Ozbilge, Charles LeVea, Allen Y Chung, Qingsheng Li, and Nejat K Egilmez, OncoImmunology, 1/1/2015
• Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models  
  H Zhang, B L Hylander, C LeVea, E A Repasky, R M Straubinger, A A Adjei and W W Ma, British Journal of Cancer, 1/1/2014
• Oral interleukin-10 alleviates polyposis via neutralization of pathogenic T-regulatory cells  
  Chu, Allen, Qingsheng Li, Sarah J. Blair, et al, Cancer Res, 1/1/2014
• Breast Cancer Resistance Protein (BCRP) and excision repair cross complement-1 (ERCC1) expression in esophageal cancers and response to Cisplatin and Irinotecan based ...  
  Sana Saif Ur Rehman, Jennifer Black, Charles LeVea, Usha Malhotra, and Renuka Iyer, J Gastrointest Oncol, 1/1/2014
• An ectopic biliary calculus mimicking gastric neoplasm: A late complication of spilled gallstones  
  Raed M. Alnaji, Moshim Kukar, Amanpal Singh, Charles M. LeVea, Steven N. Hochwald, Surgery, 1/1/2014
• Outcomes of Endoscopic Resection for High-Grade Dysplasia and Esophageal Cancer  
  Nurkin Steven J; Nava Hector R; Yendamuri Sai; LeVea Charles M; Nwogu Chumy E; Groman Adrienne; Wilding Gregory; Bain Andrew J; Hochwald Steven N; Khushalani Nikhil I, Surgical Endoscopy, 1/1/2014
• Neoadjuvant chemoradiotherapy for esophageal/gastroesophageal carcinoma  
  Timothy A. Platz, Steven J. Nurkin, Mei Ka Fong, Adrienne Groman, Leayn Flaherty, Usha Malhotra, Charles M. LeVea, Sai Yendamuri, Graham W. Warren, Hector R. Nava, Kil..., Journal of Gastrointestinal Oncology, 1/1/2013
• Erlotinib and Radiation Therapy for Elderly Patients with Esophageal Cancer - Clinical and Correlative Results from a Prospective Multicenter Phase 2 Trial  
  Iyer R. Chhatrala R. Shefter T. Yang G. Malhotra U. Tan W. LeVea C. Robins M. Khushalani N, Oncology, 1/1/2013
• Nephrogenic Adenoma of the Urinary Tract: A Review  
  Alexiev, B. A, and LeVea, C. M, Int J Surg Pathol., 1/1/2012
• The Advances in Molecular Biology of Hepatoblastoma: Implications for Diagnostic Pathology  
  Weiwei Chen, MD, PhD; Rafal Kozielski, MD; Charles LeVea, MD, PhD; Frank Chen, MD, PhD, N A J Med Sci, 1/1/2012
• Secondary Tumors of the Pancreas: Case Report and a Single-Center Experience  
  Dewanwala, A; Kotowski, A; LeVea, C. M; and Ma, W. W, J Gastrointest Canc, 1/10/2011
• Knockdown of Ron kinase inhibits mutant PI3 kinase and reduces metastasis in human colon carcinoma  
  Wang J, Rajput A, Kan JL, Rose R, Liu XQ, Kuropatwinski K, Hauser J, Beko A, Dominquez I, Sharratt EA, Brattain L, LeVea C, Sun FL, Keane DM, Gibson NW, Brattain MG, J Biol Chem, 1/1/2009
• The effects of epidermal growth factor receptor activation and attenuation of the TGFbeta pathway in an orthotopic model of colon cancer  
  Ongchin M, Sharratt E, Dominguez I, Simms N, Wang J, Cheney R, LeVea C, Brattain M, Rajput A, 1/1/2009
• EGFR Activation in Isolation is Insufficient for a Metastatic Phenotype in an Orthotopic Colon Cancer Model  
  I. Dominguez, E. Sharratt, C. LeVea, J. Wang, M. Brattain, A. Rajput, J Surg Res, 1/1/2009
•  
  M. Ongchin, E. Sharratt, I. Dominguez, C. LeVea, R. Cheney, J. Wang, M. Brattain, A. Rajput, J Surg Res, 1/1/2009
• The characterization of PI3K mutations in an orthotopic model of colon cancer  
  Melanie Ongchin, MD, Elizabeth Sharratt, BS, LVT, Ivan Dominguez, MD, Jing Wang, PhD, Charles LeVea, MD, PhD, Michael Brattain, PhD, Ashwani Rajput, MD, FACS, Journal of the American College of Surgeons, 1/1/2009
• Pilot study of Gefitinib, Oxaliplatin, and radiotherapy for esophageal adenocarcinoma: Tissue effect predicts clinical response  
  Milind Javle, MD; Amitkumar Pande, MD; Renuka Iyer, MD; Gary Yang, MD; Charles LeVea, MD, PhD; Gregory Wilding, PhD; Jennifer Black, PhD; Hector Nava, MD; Chukwumere N..., American Journal of Clinical Oncology, 1/1/2008
• Characterization of HCT 116 Human Colon Cancer Cells in an Orthotopic Model  
  Rajput A, Dominguez I, Rose R, Beko A, LeVea C, Sharratt E, Mazurchuk R, Brattain MG, Wang J, J Surg Res, 1/1/2008
• Phase II Study of Weekly Intravenous Oxaliplatin Combined With Oral Daily Capecitabine and Radiotherapy With Biologic Correlates in Neoadjuvant Treatment of Rectal Ade...  
  Marwan G. Fakih , Kelli BullardDunn, Gary Y. Yang, Lakshmi Pendyala, Karoly Toth, Chris Andrews, Youcef M.Rustum, Mary Ellen Ross, Charles LeVea, Ajithkumar Puthillath..., International Journal of Radiation Oncology, Biology, Physics, 1/1/2008
• Cytokeratin Staining to Detect Residual Disease in Patients Undergoing Neoadjuvant Chemoradiation followed by Esophagectomy for Locally Advanced Esophageal Cancer  
  M. K. Chadha, C. M. LeVea, T. Mashtare, G. Wilding, M. M. Javle & C. E. Nwogu, Internet Journal of Oncology, 1/1/2008
• CD-24 Expression is an Independent Prognostic Marker in Cholangiocarcinoma  
  Agrawal, S., Khoury, T., LeVea, C., Gibbs, J., J Gastrointest Surg, 1/1/2007
• Mutant PIK3CA bearing colon cancer cells display increased metastasis in an orthotopic model  
  Guo X, Rajput A, Rose R, Hauser J, Beko A, Kuropatwinski K, LeVea C, Hoffman RM, Brattain MG, Wang J, Cancer Res, 1/1/2007
• Characterization of two human isogenic colon cancer subclones in an orthotopic model  
  I. Dominguez, R. Rose, C. LeVea, E. Sharratt, K. Bullard Dunn, M. Brattain, A. Rajput, J Surg Res, 1/1/2007
• Epidermal Growth Factor Receptor (EGFR) Directed Therapy in Esophageal Cancer  
  A.U. Pande, MD; R.V.Iyer; A. Rani MD; S. Maddipatla MD; G.Y. Yang, MD; C.E. Nwogu, MD; J.D. Black PhD; C. M. LeVea M.D., Ph.D, M.M. Javle MD., Oncology, 1/1/2007
• Join now to see all

Books/Book Chapters

• Minimally Invasive Foregut Surgery for Malignancy 
  Chapter: Pathogenesis of Esophageal Cancer. Chapter 1 
  LeVea, Charles M. M.D., Ph.D.Editors: Steven Hochwald, Moshim Kukar.Springer International Publishing, Switzerland2015

Abstracts/Posters

• A phase Ib study of FGFR/VEGFR inhibitor dovitinib (D) combined with gemcitabine (G) and capecitabine (C) in advanced pancreatic cancer patients
  Wen Wee Ma, Gerald Fetterly, Charles LeVea, Yujie Zhao, Grace K Dy, Renuka Iyer, Wei Tan, William Brady, Amy Whitworth, Alex A Adjei, European Society for Medical Oncology, 1/1/2016
• Diagnosis of Appendiceal Mucinous Neoplasms: Variability Among Pathologists And Impact On Clinical Course.
  Al-Sukhni, Eisar; LeVea, Charles; Skitzki, Joseph; Kane, John; and Francescutti, Valerie, Society of Surgical Oncology, 1/1/2016
• Synoptic Reports Improve Completeness of Pathologic Reporting For Appendiceal Mucinous Neoplasms.
  Al-Sukhni, Eisar; LeVea, Charles; Skitzki, Joseph; Kane, John; and Francescutti, Valerie, Society of Surgical Oncology, 1/1/2016
• Utilizing Ki67 score to predict optimal liver directed treatment in patients with metastatic neuroendocrine tumors.
  Singla, Smit; K. Attwood, Kristopher; LeVea, Charles; Hochwald, Steven, GI ASCO & Society of Surgical Oncology, 1/1/2015
• A phase Ib study of the FGFR/VEGFR inhibitor dovitinib (D) combined with gemcitabine (G) and Capecitabine (C) in patients with advanced pancreatic and biliary tract ca...
  Wen Wee Ma, Gerald J. Fetterly, Charles LeVea, Yujie Zhao, Grace K. Dy, Renuka V. Iyer, Wei Tan, William E. Brady, Amy Whitworth, Alex A. Adjei, GI ASCO Conference, 1/1/2015
• Reappraisal of Subserosal Invasion in Patients with pT3 Colorectal Cancer by Elastic Stain: Clinicopathologic Study of 129 Surgical Cases with Special Reference to Per...
  Yukihiro Nakanishi MD, Charles LeVea MD, Shiva Dibaj MS, Fadi Habib MD, Richard Cheney and Kazunori Kanehira MD, USCAP Annual Meeting, 1/1/2015
• Engraftment of Resected Pancreatic Adenocarcinoma in SCID mice and Patient Survival Following Surgical Resection: Roswell Park’s Experience
  Aranez JL, Jitawatanarat P, Hylander B, Pitoniak R, LeVea C, Repasky ES, and Ma WW, GI ASCO Conference, 1/1/2014
• Inflammation and sexual dimorphism in development of insulin resistance: a dual animal model comparison.
  Zachary A.P. Wintrob, Emmanuel K. Oppong, Yu C. Tse, Hans R. Boateng, Jeffery M. Welt, Michael Martorana, John Irlam, Charles M. LeVea, Silviu L. Faitar, Alice C. Ceac..., Experimental Biology Conference, 1/1/2013
• A novel Smac mimetic, exerts significant anti-tumor efficacy in primary pancreatic adenocarcinoma model.
  Wen Wee Ma, Hao Zhang, Bonnie L. Hylander, Charles LeVea, Elizabeth A. Repasky, David Weng, Jennifer Burns, Srinivas Chunduru, Martin Graham, Gerald Fetterly, Mark McK..., 103rd AACR Annual Meeting, 1/1/2012
• Birinapant, a novel Smac mimetic, exerts significant anti-tumor efficacy in primary pancreatic adenocarcinoma model.
  Wen Wee Ma, Hao Zhang, Bonnie L. Hylander, Charles LeVea, Elizabeth A. Repasky, David Weng, Jennifer Burns, Srinivas Chunduru, Martin Graham, Gerald Fetterly, Mark McK..., AACR Meeting, 1/1/2012
• Outcomes of Endoscopic Resection for High Grade Dysplasia and Esophageal Cancer.
  Hector Nava, MD, Chukwumere Nwogu, MD, Sai Yendamuri, MD, MD, Charles M. LeVea, MD, PhD, Nikhil Khushalani, MD, Digestive Disease Week Meeting & American College of Surgeons' 98th Annual Clinical Congress, 1/1/2012
• Phase II multicenter study of erlotinib with radiation therapy (RT) for elderly patients (pts) with esophageal carcinoma (EC): Final report.
  R. R. V. Iyer, G. Yang, T. E. Schefter, W. Tan, H. R. Nava, C. Levea, A. Litwin, M. Robins, N. I. Khushalani, GI ASCO Meeting, 1/1/2011
• Most Metastatic Colorectal Adenocarcinomas Express Less CDX2 than their Primaries.
  Rongjun Guo, Frank Chen, Joyce Paterson, John P. Lynch, Amy Sands, Carl Morrison, Charles LeVea, USCAP Meeting, 1/1/2011
• Secondary tumors of the pancreas: Case report and a single center experience.
  Akriti Dewanwala MBBS, Adam Kotowski MD, Charles LeVea MD, PhD, and Wen Ma, MD, Connecticut ACP Chapter Meeting, 1/1/2010
• Continuous and intermittent Vorinostat in combination with FOLFIRI in advanced upper gastrointestinal cancer: Preliminary results of a phase I pharmacokinetic study.
  Khushalani, Brady, Fetterly, Prey, LeVea, Litwin, Grande, Iyer, Javle, EMSO Meeting, 1/1/2010
• Phase II multicenter study of Erlotinib in combination with radiation therapy for elderly patients with esophageal carcinoma - Final report.
  R Iyer, G Yang, T Shefter, W Tan, H Nava, A Litwin, C LeVea, M Robins, N Khushalani, EMSO Meeting, 1/1/2010
• Phase II multicenter study of Erlotinib with radiation therapy for elderly patients with esophageal carcinoma - final report.
  R. V. Iyer, G. Yang, T. E. Schefter, W. Tan, H. R. Nava, C. LeVea, A. Litwin, M. Robins, N. I. Khushalani, GI ASCO Meeting, 1/1/2010
• A Phase II study of Erlotinib in patients with advanced pancreatic cancer, who are refractory to Gemcitabine.
  R. V. Iyer, N. I. Khushalani, W. Tan, A. Litwin, P. Starostik, C. LeVea, C. Tucker, W. W. Ma, M. Fakih, A. A. Adjei, GI ASCO Meeting, 1/1/2010
• A phase I pharmacokinetic study of vorinostat in combination with irinotecan, 5-fluorouracil and leucovorin (FOLFIRI) in advanced upper gastrointestinal cancers (AGC)
  G. J. Fetterly, W. E. Brady, C. M. LeVea, A. M. Litwin, P. D. Zagst, J. D. Prey, M. Tarquini, M. K. Giardina, R. V. Iyer, N. I. Khushalani, ASCO Annual Meeting, 1/1/2009
• First Reported Case of Primary Clear Cell Sarcoma of Liver: Diagnostic Conundrum
  Chintanaboina, J; LeVea, C; and Iyer, R, Digestive Disease Week, 1/1/2009
• A Phase II study of Erlotinib in patients with advanced pancreatic cancer, who are refractory to Gemcitabine.
  R. V. Iyer, N. I. Khushalani, W. Tan, A. Litwin, P. Starostik, C. LeVea, C. Tucker, W. W. Ma, M. Fakih, A. A. Adjei, EMSO Meeting, 1/1/2009
• Gefitinib (ZD1839) with Oxaliplatin and Radiotherapy for Esophageal Carcinoma.
  Amitkumar Pande, Renuka Iyer, Hector Nava, Gary Yang, Chumy Nwogu, Michael Schiff, Charles LeVea, Jennifer Black, Milind Javle, ASCO Annual Meeting, 1/1/2007
• Cytokeratin staining to predict residual disease in patients undergoing neoadjuvant chemoradiation for esophageal cancer.
  M. K. Chadha, P. Lin, M. Javle, R. Iyer, D. Driscoll, H. Nava, G Yang, C. LeVea, ASCO Annual Meeting, 1/1/2007
• EGFR, p-Erk and p-Akt expression in Barrett’s esophagus (BE): a prospective pilot study.
  Abha Rani, Milind Javle, Charles LeVea, Jihnhee Yu, Michael Brattain, Jennifer Black, Digestive Disease Week, 1/1/2007
• Characterization of two human isogenic colon cancer subclones in an orthotopic model.
  Dominguez I, Rose R, LeVea C, Sharratt E, Brattain M, Rajput A, Symposium on Advances in Cell Signaling, Cancer Prevention & Therapy, South Padre Island, TX, 1/10/2006
• Join now to see all

Lectures

• Making a Treatment Plan: Multidisciplinary Panel 
  Amherst, NY - 1/29/2015
• Colon Morphology and Molecular Biology 
  1/1/2015
• Gastrointestinal Pathology 
  1/1/2015
• PTR 536 Cancer Pathology 
  1/1/2015
• Multidisciplinary Management of NET Cancer 
  Amherst, NY - 1/29/2013
• Multimodality Treatment of Colon Cancer 
  Menorah Medical Center, Overland Park, KS - 1/30/2007
• Core Lecture Series: The diagnosis of pancreatic neoplasms. 
  Buffalo General Hospital, Buffalo, NY - 1/10/2006
• The diagnosis of pancreatic neoplasms. 
  Buffalo General Hospital, Buffalo, NY - 1/16/2004
• The pathology of gastrointestinal stromal tumors. 
  Roswell Park Cancer Institute, Buffalo, NY - 1/6/2004
• Join now to see all